MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study

    E.F Alvarez, C. Spanaki, E. Pekkonen, L. Manzanares, Y. Liu, O. Sánchez-Soliño, L. Barbato (Elche, Spain)

  • Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson’s disease patients

    A. Lees, O. Rascol, J. Ferreira, O. Klepitskaya, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)

  • Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson’s disease patients with motor fluctuations

    A. Videnovic, W. Poewe, A. Lees, J. Ferreira, O. Klepitskaya, R. Loureiro, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Boston, MA, USA)

  • Effect of opicapone and entacapone on levodopa short duration response

    P. LeWitt, J. Ferreira, G. Ebersbach, E. Tolosa, G. Liang, R. Loureiro, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Detroit, MI, USA)

  • Effect of P2X4 Signal Axis on Iron Metabolism in Parkinson’s Disease Animal Model

    A. Xie, J. Gao, J. Ma (Qingdao, China)

  • Effect of regular practice of yoga versus aerobic exercise on motor and non motor signs and motor cortex plasticity in Parkinson’s disease

    A. Kishore, P. James, A. Thejaus, S. Krishnan, K. Divya, S. Meunier (Trivandrum, India)

  • Effect of repetitive transcranial magnetic stimulation with intensive physical therapy in cerebellar ataxia: A pilot study

    J.H. Ahn, J. Song, M. Kim, J.K. Mun, J.S. Kim, J.W. Cho, W.H. Chang, J. Youn (Seoul, Republic of Korea)

  • Effect of the MAO-B inhibitor and glutamate modulator safinamide on depressive symptoms in three Parkinson’s disease patients

    W.E Hofmann (Aschaffenburg, Germany)

  • Effect on somatosensory pathway and balance control after unilateral MRgFUS Vim thalamotomy in patients with essential tremor

    J.H Chen, C.T Hong, D. Wu, C.J Hu (New Taipei City, Taiwan)

  • Effectiveness and Tolerability of Mirabegron and Behavioral Therapy in Patients with Parkinson’s Disease and Overactive Bladder: A Prospective, Randomized, Placebo-Controlled Pilot Study

    S. Ray, D. Burdick, P. Agarwal, A. Madan (Kirkland, WA, USA)

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley